EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk.

I. M. Wilson, E. A. Vucic, K. S.S. Enfield, K. L. Thu, Y. A. Zhang, R. Chari, W. W. Lockwood, N. Radulovich, D. T. Starczynowski, J. P. Banáth, M. Zhang, A. Pusic, M. Fuller, K. M. Lonergan, D. Rowbotham, J. Yee, J. C. English, T. P.H. Buys, S. A. Selamat, I. A. Laird-Offringa & 11 others P. Liu, M. Anderson, M. You, M. S. Tsao, C. J. Brown, K. L. Bennewith, C. E. MacAulay, A. Karsan, A. F. Gazdar, S. Lam, W. L. Lam

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

In an effort to identify novel biallelically inactivated tumor suppressor genes (TSGs) in sporadic invasive and preinvasive non-small-cell lung cancer (NSCLC) genomes, we applied a comprehensive integrated multiple 'omics' approach to investigate patient-matched, paired NSCLC tumor and non-malignant parenchymal tissues. By surveying lung tumor genomes for genes concomitantly inactivated within individual tumors by multiple mechanisms, and by the frequency of disruption in tumors across multiple cohorts, we have identified a putative lung cancer TSG, Eyes Absent 4 (EYA4). EYA4 is frequently and concomitantly deleted, hypermethylated and underexpressed in multiple independent lung tumor data sets, in both major NSCLC subtypes and in the earliest stages of lung cancer. We found that decreased EYA4 expression is not only associated with poor survival in sporadic lung cancers but also that EYA4 single-nucleotide polymorphisms are associated with increased familial cancer risk, consistent with EYA4s proximity to the previously reported lung cancer susceptibility locus on 6q. Functionally, we found that EYA4 displays TSG-like properties with a role in modulating apoptosis and DNA repair. Cross-examination of EYA4 expression across multiple tumor types suggests a cell-type-specific tumorigenic role for EYA4, consistent with a tumor suppressor function in cancers of epithelial origin. This work shows a clear role for EYA4 as a putative TSG in NSCLC.

Original languageEnglish (US)
Pages (from-to)4464-4473
Number of pages10
JournalOncogene
Volume33
Issue number36
DOIs
StatePublished - 2014

Fingerprint

Lung Neoplasms
Tumor Suppressor Genes
Non-Small Cell Lung Carcinoma
Neoplasms
Eye Neoplasms
Genome
Naphazoline
Esotropia
Lung
DNA Repair
Single Nucleotide Polymorphism
Apoptosis
Survival
Genes

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Wilson, I. M., Vucic, E. A., Enfield, K. S. S., Thu, K. L., Zhang, Y. A., Chari, R., ... Lam, W. L. (2014). EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk. Oncogene, 33(36), 4464-4473. https://doi.org/10.1038/onc.2013.396

EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk. / Wilson, I. M.; Vucic, E. A.; Enfield, K. S.S.; Thu, K. L.; Zhang, Y. A.; Chari, R.; Lockwood, W. W.; Radulovich, N.; Starczynowski, D. T.; Banáth, J. P.; Zhang, M.; Pusic, A.; Fuller, M.; Lonergan, K. M.; Rowbotham, D.; Yee, J.; English, J. C.; Buys, T. P.H.; Selamat, S. A.; Laird-Offringa, I. A.; Liu, P.; Anderson, M.; You, M.; Tsao, M. S.; Brown, C. J.; Bennewith, K. L.; MacAulay, C. E.; Karsan, A.; Gazdar, A. F.; Lam, S.; Lam, W. L.

In: Oncogene, Vol. 33, No. 36, 2014, p. 4464-4473.

Research output: Contribution to journalArticle

Wilson, IM, Vucic, EA, Enfield, KSS, Thu, KL, Zhang, YA, Chari, R, Lockwood, WW, Radulovich, N, Starczynowski, DT, Banáth, JP, Zhang, M, Pusic, A, Fuller, M, Lonergan, KM, Rowbotham, D, Yee, J, English, JC, Buys, TPH, Selamat, SA, Laird-Offringa, IA, Liu, P, Anderson, M, You, M, Tsao, MS, Brown, CJ, Bennewith, KL, MacAulay, CE, Karsan, A, Gazdar, AF, Lam, S & Lam, WL 2014, 'EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk.', Oncogene, vol. 33, no. 36, pp. 4464-4473. https://doi.org/10.1038/onc.2013.396
Wilson, I. M. ; Vucic, E. A. ; Enfield, K. S.S. ; Thu, K. L. ; Zhang, Y. A. ; Chari, R. ; Lockwood, W. W. ; Radulovich, N. ; Starczynowski, D. T. ; Banáth, J. P. ; Zhang, M. ; Pusic, A. ; Fuller, M. ; Lonergan, K. M. ; Rowbotham, D. ; Yee, J. ; English, J. C. ; Buys, T. P.H. ; Selamat, S. A. ; Laird-Offringa, I. A. ; Liu, P. ; Anderson, M. ; You, M. ; Tsao, M. S. ; Brown, C. J. ; Bennewith, K. L. ; MacAulay, C. E. ; Karsan, A. ; Gazdar, A. F. ; Lam, S. ; Lam, W. L. / EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk. In: Oncogene. 2014 ; Vol. 33, No. 36. pp. 4464-4473.
@article{fcc1a8df66fe4fc0b03250068b2e3dab,
title = "EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk.",
abstract = "In an effort to identify novel biallelically inactivated tumor suppressor genes (TSGs) in sporadic invasive and preinvasive non-small-cell lung cancer (NSCLC) genomes, we applied a comprehensive integrated multiple 'omics' approach to investigate patient-matched, paired NSCLC tumor and non-malignant parenchymal tissues. By surveying lung tumor genomes for genes concomitantly inactivated within individual tumors by multiple mechanisms, and by the frequency of disruption in tumors across multiple cohorts, we have identified a putative lung cancer TSG, Eyes Absent 4 (EYA4). EYA4 is frequently and concomitantly deleted, hypermethylated and underexpressed in multiple independent lung tumor data sets, in both major NSCLC subtypes and in the earliest stages of lung cancer. We found that decreased EYA4 expression is not only associated with poor survival in sporadic lung cancers but also that EYA4 single-nucleotide polymorphisms are associated with increased familial cancer risk, consistent with EYA4s proximity to the previously reported lung cancer susceptibility locus on 6q. Functionally, we found that EYA4 displays TSG-like properties with a role in modulating apoptosis and DNA repair. Cross-examination of EYA4 expression across multiple tumor types suggests a cell-type-specific tumorigenic role for EYA4, consistent with a tumor suppressor function in cancers of epithelial origin. This work shows a clear role for EYA4 as a putative TSG in NSCLC.",
author = "Wilson, {I. M.} and Vucic, {E. A.} and Enfield, {K. S.S.} and Thu, {K. L.} and Zhang, {Y. A.} and R. Chari and Lockwood, {W. W.} and N. Radulovich and Starczynowski, {D. T.} and Ban{\'a}th, {J. P.} and M. Zhang and A. Pusic and M. Fuller and Lonergan, {K. M.} and D. Rowbotham and J. Yee and English, {J. C.} and Buys, {T. P.H.} and Selamat, {S. A.} and Laird-Offringa, {I. A.} and P. Liu and M. Anderson and M. You and Tsao, {M. S.} and Brown, {C. J.} and Bennewith, {K. L.} and MacAulay, {C. E.} and A. Karsan and Gazdar, {A. F.} and S. Lam and Lam, {W. L.}",
year = "2014",
doi = "10.1038/onc.2013.396",
language = "English (US)",
volume = "33",
pages = "4464--4473",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "36",

}

TY - JOUR

T1 - EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk.

AU - Wilson, I. M.

AU - Vucic, E. A.

AU - Enfield, K. S.S.

AU - Thu, K. L.

AU - Zhang, Y. A.

AU - Chari, R.

AU - Lockwood, W. W.

AU - Radulovich, N.

AU - Starczynowski, D. T.

AU - Banáth, J. P.

AU - Zhang, M.

AU - Pusic, A.

AU - Fuller, M.

AU - Lonergan, K. M.

AU - Rowbotham, D.

AU - Yee, J.

AU - English, J. C.

AU - Buys, T. P.H.

AU - Selamat, S. A.

AU - Laird-Offringa, I. A.

AU - Liu, P.

AU - Anderson, M.

AU - You, M.

AU - Tsao, M. S.

AU - Brown, C. J.

AU - Bennewith, K. L.

AU - MacAulay, C. E.

AU - Karsan, A.

AU - Gazdar, A. F.

AU - Lam, S.

AU - Lam, W. L.

PY - 2014

Y1 - 2014

N2 - In an effort to identify novel biallelically inactivated tumor suppressor genes (TSGs) in sporadic invasive and preinvasive non-small-cell lung cancer (NSCLC) genomes, we applied a comprehensive integrated multiple 'omics' approach to investigate patient-matched, paired NSCLC tumor and non-malignant parenchymal tissues. By surveying lung tumor genomes for genes concomitantly inactivated within individual tumors by multiple mechanisms, and by the frequency of disruption in tumors across multiple cohorts, we have identified a putative lung cancer TSG, Eyes Absent 4 (EYA4). EYA4 is frequently and concomitantly deleted, hypermethylated and underexpressed in multiple independent lung tumor data sets, in both major NSCLC subtypes and in the earliest stages of lung cancer. We found that decreased EYA4 expression is not only associated with poor survival in sporadic lung cancers but also that EYA4 single-nucleotide polymorphisms are associated with increased familial cancer risk, consistent with EYA4s proximity to the previously reported lung cancer susceptibility locus on 6q. Functionally, we found that EYA4 displays TSG-like properties with a role in modulating apoptosis and DNA repair. Cross-examination of EYA4 expression across multiple tumor types suggests a cell-type-specific tumorigenic role for EYA4, consistent with a tumor suppressor function in cancers of epithelial origin. This work shows a clear role for EYA4 as a putative TSG in NSCLC.

AB - In an effort to identify novel biallelically inactivated tumor suppressor genes (TSGs) in sporadic invasive and preinvasive non-small-cell lung cancer (NSCLC) genomes, we applied a comprehensive integrated multiple 'omics' approach to investigate patient-matched, paired NSCLC tumor and non-malignant parenchymal tissues. By surveying lung tumor genomes for genes concomitantly inactivated within individual tumors by multiple mechanisms, and by the frequency of disruption in tumors across multiple cohorts, we have identified a putative lung cancer TSG, Eyes Absent 4 (EYA4). EYA4 is frequently and concomitantly deleted, hypermethylated and underexpressed in multiple independent lung tumor data sets, in both major NSCLC subtypes and in the earliest stages of lung cancer. We found that decreased EYA4 expression is not only associated with poor survival in sporadic lung cancers but also that EYA4 single-nucleotide polymorphisms are associated with increased familial cancer risk, consistent with EYA4s proximity to the previously reported lung cancer susceptibility locus on 6q. Functionally, we found that EYA4 displays TSG-like properties with a role in modulating apoptosis and DNA repair. Cross-examination of EYA4 expression across multiple tumor types suggests a cell-type-specific tumorigenic role for EYA4, consistent with a tumor suppressor function in cancers of epithelial origin. This work shows a clear role for EYA4 as a putative TSG in NSCLC.

UR - http://www.scopus.com/inward/record.url?scp=84908495622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908495622&partnerID=8YFLogxK

U2 - 10.1038/onc.2013.396

DO - 10.1038/onc.2013.396

M3 - Article

VL - 33

SP - 4464

EP - 4473

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 36

ER -